Tynwald members have warned Manx Care is heading for a significant overspend based on “optimistic assumptions” and “fiscal magical thinking”.
The mandate and operating plan for the coming financial year were debated in Tynwald this week, with the health body receiving a £42 million (12%) uplift for the forthcoming year.
Minister for Health and Social Care Claire Christian said the documents represented “the most significant step change since Manx Care’s creation”.
However, Gary Clueit MLC delivered a stark warning, claiming the budget was built on “optimistic assumptions, unresolved systemic flaws, and what I can only describe as fiscal magical thinking”.
Mr Clueit pointed to a “terrifying” gap between the inflation uplift provided and actual healthcare cost pressures.
“The operating plan itself admits that UK CPI is running at 3.8 per cent and more terrifyingly, that healthcare inflation is running at over 17 per cent during 25/26,” he said.
“A mandate that expects Manx Care to absorb 17 per cent medical inflation with a 2.9 per cent inflationary uplift guarantees an overspend before the ink is even dry.”
Savings
The MLC also raised serious concerns about the requirement for Manx Care to deliver £9.7 million in recurring savings.
He concluded with a stark assessment of the island’s position: “We are hurtling towards a cliff edge where the only two realistic options remain, either we must seriously look at rationalising services, or if we are absolutely committed to maintaining the current breadth and depth of universal provision, we must be honest with taxpayers that it will require raising taxes to pay for it.
“There is no magical third option.”
Concerns
Joney Faragher raised concerns about the mandate’s approach to NICE technology appraisals, warning that a “cost neutral” test was ruling out interventions that could deliver long-term savings.
“Most NICE appraisals aren’t cost neutral in the short term, so implementation is being quietly limited here,” she said.
“It creates the appearance of compliance with NICE standards, while allowing non-implementation on financial grounds, but without requiring transparency on what’s being rejected and why.”
She cited weight-loss medications including Wegovy and Mounjaro, introduced in the UK following NICE approval, as examples of treatments that require upfront investment but reduce future demand.
“We’re ruling out the very interventions that could deliver the greatest long-term benefits, both for patients and for the sustainability of the system,” she said.
Mandate
However, Ms Christian defended the mandate’s approach, saying cautious language reflected responsible commissioning rather than a lack of ambition.
“The mandate is deliberately honest about the tension, rather than obscuring it,” she said.
“I did not want anything in that mandate that hadn’t been funded, because we have done that in the past where we’ve set ourselves up for that fall.”
Chief Minister Alf Cannan seconded the debate, saying he was encouraged that Manx Care’s chief executive had confirmed “the budget and the mandate are fully aligned and that the organisation considers the funding this year to be properly funded”.